Nutshell Therapeutics (Shanghai) Co., LTD.
1 clinical trials · Sponsor
◉ Watch Nutshell Therapeutics (Shanghai) Co., LTD.
| Record | Firm | Date |
|---|---|---|
| A Study of Safety, Tolerability and Preliminary Efficacy of NTS071 in Subjects With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (NCT07060989) | Nutshell Therapeutics (Shanghai) Co., LTD. | 2025-08-04 |
Track Nutshell Therapeutics (Shanghai) Co., LTD. automatically
Every clearance here is in the API, with alerts when new ones post.